Entrectinib 100mg Capsules

100mg Capsule, Bottle

4.5 (154)

13,500

Rozlytrek 100mg Capsule is an oral tyrosine kinase inhibitor targeting NTRK, ROS1, and ALK fusion proteins, used to treat NTRK fusion-positive solid tumors and ROS1-positive non-small cell lung cancer. It works by inhibiting TRK A/B/C kinases and blocking ROS1 and ALK signaling, suppressing tumor growth across multiple tissue types in a tumor-agnostic approach based on actionable gene fusions. Common side effects include dizziness, weight gain, and fatigue, so regular monitoring of neurologic symptoms and cardiac function is recommended during treatment.

Description

Information Of Rozlytrek 100mg Capsule:

Rozlytrek 100mg Capsule contains entrectinib, a tyrosine-kinase inhibitor used to treat adult patients with advanced non-small cell lung cancer (NSCLC) whose tumours are ROS1-positive, and adult and paediatric patients aged 12 years and older with solid tumours that harbour a neurotrophic tyrosine receptor kinase (NTRK) gene fusion without a known acquired resistance mutation. It works by inhibiting ROS1 and TRK (A/B/C) fusion-driven kinase activity, thereby blocking abnormal signalling pathways that drive tumour growth and survival, helping to slow disease progression and improve patient outcomes.

Active Ingredient/Salt Of Rozlytrek 100mg Capsule:

  • Entrectinib

Benefits Of Rozlytrek 100mg Capsule:

  • Targets ROS1-positive NSCLC and NTRK fusion-positive solid tumours, providing a precision-medicine approach
  • Capable of crossing the blood-brain barrier in ROS1-positive NSCLC
  • Demonstrated objective response in multiple tumour types in clinical trials
  • Provides a treatment option for patients with limited alternatives
  • Manufactured by Roche, a global leader in oncology therapeutics

Good to Know about Rozlytrek 100mg Capsule:

  • Manufactured under WHO-GMP standards to ensure quality and safety
  • Storage: Store below 30 °C in a dry place, protected from moisture and light
  • Prescription-only medicine; should be used under specialist supervision

Allergen Information:

  • May contain standard pharmaceutical excipients
  • Not suitable for individuals allergic to entrectinib or similar TRK/ROS1 inhibitors

Directions for Use:

  • Taken orally with or without food, as advised by your doctor
  • Swallow the capsule whole; do not crush, chew, or open it
  • Do not change the dose or schedule without medical guidance
  • Continue treatment until disease progression or unacceptable toxicity, unless otherwise directed
  • Typical dose adjustments may reduce from 100 mg to lower doses if adverse effects occur, as prescribed by your doctor

Safety Information about Rozlytrek 100mg Capsule:

  • Common side effects include fatigue, nausea, constipation, taste changes, swelling, dizziness, diarrhea, vision disorders, cough, and weight increase
  • May cause serious reactions such as heart failure, cognitive impairment, fractures, liver injury, and heart rhythm abnormalities
  • Not recommended during pregnancy or breastfeeding; effective contraception required for both males and females during treatment
  • Regular monitoring of liver function, ECG, and bone health may be necessary
  • Avoid driving or operating heavy machinery if experiencing dizziness, vision changes, or cognitive impairment
  • Keep out of reach of children and dispose of unused medicine responsibly

Contact Us

Info Table
Composition Entrectinib
Strength 100 mg
Brand Name LuciEntre
Packaging Size 60 Capsules
Form Capsule
Manufacturer Lucius Pharma
Packaging Type Bottle
Vendor Info
Benefits
Reviews

Description

Information Of Rozlytrek 100mg Capsule:

Rozlytrek 100mg Capsule contains entrectinib, a tyrosine-kinase inhibitor used to treat adult patients with advanced non-small cell lung cancer (NSCLC) whose tumours are ROS1-positive, and adult and paediatric patients aged 12 years and older with solid tumours that harbour a neurotrophic tyrosine receptor kinase (NTRK) gene fusion without a known acquired resistance mutation. It works by inhibiting ROS1 and TRK (A/B/C) fusion-driven kinase activity, thereby blocking abnormal signalling pathways that drive tumour growth and survival, helping to slow disease progression and improve patient outcomes.

Active Ingredient/Salt Of Rozlytrek 100mg Capsule:

  • Entrectinib

Benefits Of Rozlytrek 100mg Capsule:

  • Targets ROS1-positive NSCLC and NTRK fusion-positive solid tumours, providing a precision-medicine approach
  • Capable of crossing the blood-brain barrier in ROS1-positive NSCLC
  • Demonstrated objective response in multiple tumour types in clinical trials
  • Provides a treatment option for patients with limited alternatives
  • Manufactured by Roche, a global leader in oncology therapeutics

Good to Know about Rozlytrek 100mg Capsule:

  • Manufactured under WHO-GMP standards to ensure quality and safety
  • Storage: Store below 30 °C in a dry place, protected from moisture and light
  • Prescription-only medicine; should be used under specialist supervision

Allergen Information:

  • May contain standard pharmaceutical excipients
  • Not suitable for individuals allergic to entrectinib or similar TRK/ROS1 inhibitors

Directions for Use:

  • Taken orally with or without food, as advised by your doctor
  • Swallow the capsule whole; do not crush, chew, or open it
  • Do not change the dose or schedule without medical guidance
  • Continue treatment until disease progression or unacceptable toxicity, unless otherwise directed
  • Typical dose adjustments may reduce from 100 mg to lower doses if adverse effects occur, as prescribed by your doctor

Safety Information about Rozlytrek 100mg Capsule:

  • Common side effects include fatigue, nausea, constipation, taste changes, swelling, dizziness, diarrhea, vision disorders, cough, and weight increase
  • May cause serious reactions such as heart failure, cognitive impairment, fractures, liver injury, and heart rhythm abnormalities
  • Not recommended during pregnancy or breastfeeding; effective contraception required for both males and females during treatment
  • Regular monitoring of liver function, ECG, and bone health may be necessary
  • Avoid driving or operating heavy machinery if experiencing dizziness, vision changes, or cognitive impairment
  • Keep out of reach of children and dispose of unused medicine responsibly

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Entrectinib 100mg Capsules”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Rozlytrek 100mg Capsule for?
Rozlytrek contains entrectinib and is used to treat adults and some children who have certain types of solid tumours with a gene change called NTRK, or adults with non-small cell lung cancer whose tumour has a ROS1 gene change. Your doctor will explain why it is suitable for your condition. You can find more details on MedlinePlus.
Take Rozlytrek 100mg Capsule exactly as your oncologist prescribes. It is taken by mouth, usually once a day. Swallow the capsule whole with a glass of water, and you may take it with or without food. Do not crush, chew or open the capsule.
Rozlytrek 100mg Capsule is usually not recommended during pregnancy or while breastfeeding because it might harm a developing baby. If you are pregnant, planning to become pregnant, or breastfeeding, talk to your oncologist before using it.
You must tell your doctor about all other medicines, supplements, or herbal products you are taking. Rozlytrek may interact with medicines that affect your heart rhythm, liver enzymes, brain function, or kidney function. Your doctor may do tests and adjust your treatment if needed.
Common side effects may include tiredness, nausea, dizziness, cough, trouble concentrating, changes in vision or hearing, constipation or other stomach problems. Serious side effects can include heart problems like congestive heart failure, nervous system effects such as confusion or hallucinations, bone weakness, liver problems, and very high uric acid levels. Contact your doctor immediately if you notice swelling of legs or feet, shortness of breath, yellowing of your skin or eyes, sudden bone pain, or fainting.
Store Rozlytrek 100mg Capsule in its original packaging in a cool, dry place away from direct sunlight and moisture. Keep it out of reach of children.

Related products